Silence Therapeutics

NASDAQ: SLN · Real-Time Price · USD
5.48
-0.15 (-2.66%)
At close: Aug 15, 2025, 3:59 PM
5.49
0.09%
After-hours: Aug 15, 2025, 04:10 PM EDT

Silence Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
121.33M 54.03M 54.82M 73.54M
Short-Term Investments
26M n/a 16.33M n/a
Long-Term Investments
n/a 284K 284K 301K
Other Long-Term Assets
3.59M 2.58M -10.81M -9.86M
Receivables
26.91M 228K 17.34M 8.49M
Inventory
n/a n/a -16.43M n/a
Other Current Assets
40.03M n/a n/a n/a
Total Current Assets
187.37M 81.02M 96.69M 86.33M
Property-Plant & Equipment
1.98M 1.81M 2.2M 1.94M
Goodwill & Intangibles
9.7M 8.12M 8.33M 7.62M
Total Long-Term Assets
15.27M 12.8M 10.81M 9.86M
Total Assets
202.63M 93.82M 107.5M 96.19M
Account Payables
3.7M 2.63M 3.19M 4.07M
Deferred Revenue
306K n/a 8.86M 4.25M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
3.44M 6.11M 589K 185K
Total Current Liabilities
16.82M 17.77M 21.94M 15.17M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
51.79M 59M 63.48M 72.5M
Total Liabilities
68.61M 76.77M 85.43M 87.67M
Total Debt
117K 272K 446K 137K
Common Stock
n/a 5.94M 5.39M 4.49M
Retained Earnings
-474.04M -304.61M -263.26M -222.97M
Comprehensive Income
-11.78M 64.27M 24.33M 23.79M
Shareholders Equity
134.02M 17.05M 22.07M 8.53M
Total Investments
26M 284K 16.61M 301K